Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease
- 30 November 2011
- journal article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 94 (2), 167-171
- https://doi.org/10.1016/j.diabres.2011.06.020
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Platelet release of β-thromboglobulin and platelet factor 4 and serotonin in plasma samplesClinical Biochemistry, 2005
- Kidney in Early AtherosclerosisHypertension, 2005
- Lipid Inflammatory Mediators in Diabetic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular diseaseJournal of Laboratory and Clinical Medicine, 2004
- High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasmaClinical Biochemistry, 2004
- Inflammatory Reactions in the Pathogenesis of AtherosclerosisJournal of Atherosclerosis and Thrombosis, 2003
- Endothelial Dysfunction, Hemodynamic Forces, and AtherogenesisaAnnals of the New York Academy of Sciences, 2000
- Effect of streptozotocin-induced diabetes mellitus on serotonin measures of peripheral tissues in ratsLife Sciences, 1994
- Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitusThrombosis Research, 1992
- Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular diseaseEuropean Journal of Clinical Investigation, 1988